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ABSTRACT OF THE THESIS
A COMPUTATIONAL METHOD FOR INTERNAL RADIATION DOSIMETRY AT
THE VOXEL LEVEL
by
Swapna Chigurupati
Florida International University, 2003
Miami, Florida
Professor Juan Franquiz, Major Professor
The current development of hybrid SPECT/CT and PET/CT systems allows not only
accurate attenuation correction of images, but also provide an anatomical frame for the
3D spatial representation of the dose distribution. The main goal of this thesis project was
to develop computational algorithms for calculation of the 3D dose distribution delivered
by internal emitters based on the images and information provided by new hybrid
SPECT/CT and PET/CT systems. Although many experimental problems exist in patient-
specific dosimetry, current drawback is the lack of radionuclide voxel S values for the set
of all possible combinations of cubical and non-cubical pixel edges and thickness used in
SPECT and PET studies. This work presents an alternative and computationally efficient
method for calculating voxel S values based on the Monte Carlo volume integration of
tabulated dose point-kernels of beta emissions over a voxel-to-voxel geometry. The
accuracy of the calculations was compared with those determined by direct Monte Carlo
radiation transport simulation.
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1. INTRODUCTION
1.1 Radioimmunotherapy (RIT) is a new area of medicine being studied to locate and
treat cancer within the body using Radioisotopes. RIT uses a radioactive material
attached to specially designed antibodies with internal or other compounds to locate and
treat cancer within the body. Antibodies are naturally produced by the body's immune
system. They are normally used to recognize infections caused by bacteria and viruses.
The antibodies used in RIT are monoclonal antibodies (MAbs). These antibodies are
developed in the laboratory and recognize substances on the surface of tumor cells. The
MAbs are modified to bind radioactive metals (Indium- 11 or Iodine-123), which can be
visualized with a special camera in Nuclear Medicine. Images from this camera show
areas where the MAbs have localized in the body. RIT uses the same MAbs for therapy
but switches the radioactive metal to Yttrium-90 which delivers local radiation to the
tumor. The radiolabeled MAb is administered through a vein and then circulates through
the body to the surface of tumor cells. The tumor cells are destroyed by the radiation
given off from the localized radiolabeled MAbs.
Radionuclides are administered to patients in nuclear medicine procedures in a variety of
diagnostic and therapeutic applications. A key consideration in such studies is the
absorbed dose to different organs of the patient. This concern is naturally heightened in
therapy applications, where a significant absorbed dose may be received by other organs
and in particular by radiosensitive organs.
Radionuclide therapy based on patient-specific dosimetry offers the potential for
optimizing the dose delivered to the target tumor through utilization of measured
radiopharmaceutical kinetics specific to the individual. The administered activity may be
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tailored for the patient such that the highest possible radiation dose may be given to the
tumor while limiting the dose to critical organs and tissues below any designated
threshold for negative biological effects.
1.2 Internal Dosimetry: It is the scientific methodology used to measure, calculate,
estimate, assay, predict and otherwise quantify the radioactive energy absorbed by the
ionization and excitation of atoms in human tissues as a result of the emission of
energetic radiation by internally deposited radio nuclides. Internal Dosimetry deals with
the determination of the amount and the spatial and temporal distribution of radiation
energy deposited in tissue by radionuclides within the body. Internal dose is calculated
from external measurements of activity in the patient.
Methods for acquiring quantitative data on radionuclide biodistribution and or calculation
of the radiation absorbed dose using standard anthropomorphic models were developed
by the Medical Internal Radiation Dose (MIRD) committee of the Society of Nuclear
Medicine. This system of mathematical equations for calculating the internal dosimetry
of administered radiopharmaceuticals is referred to as the MIRD schema. Computer
software tools such as MIRDOSE are available for implementing the source-organ
residence times that may be obtained from imaging and analysis of time activity curves.
The MIRD schema were originally designed to provide conservative estimates of
absorbed dose for diagnostic radiopharmaceuticals. The MIRD schema have also been
used to estimate organ doses for therapeutic radioimmunoconjugates and other
radioactive drugs (Darrell, 2000). Patient specific dosimetry refers to the estimation of
radiation dose to tissues of a specific patient, based on his or her individual body habitus
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and measured radiopharmaceutical kinetics rather then on an average anthropomorphic
model and hypothetic kinetics. In contrast to the average dose, position-specific
dosimetry refers to radiation doses to specific points in a tumor or organ and thus reflects
the spatial variation in dose within a target tissue (Zanzonocio, 2000). More recently,
MIRD pamphlet no. 17, the Dosimetry of Nonuniforin Activity Distributions:
Radionuclide S values at the Voxel Level has extended the MIRD schema to arbitrary
macroscopic activity distributions in 3 dimensions for calculation of the resulting
macroscopic dose distribution.
1.3 Internal Dosimetry using the MIRD formalism
Absorbed dose calculations require determination of patient pharmacokinetic data using a
diagnostic activity prior to the administration of the larger therapeutic activity.
Since there is no practical or accepted method for patient-specific internal dose
calculation, the formalism of the Medical Internal Dose Committee (MIRD) of the
Society of Nuclear Medicine has been used for dose calculation in most clinical trials
where the radiopharmaceutical does not distribute uniformly. The MIRD formalism
developed for radiation safety purposes in diagnostic nuclear medicine studies, calculates
organ doses per unit of activity by using a diagnostic tracer activity prior to the treatment.
This formalism is based on the use of radionuclide specific absorbed fractions, or S
values, defined as the mean absorbed dose to a target organ per radioactive decay in a
source organ. The average target organ dose is given by the product of the source organ
cumulated activity and the corresponding S value. Cumulated activity is the time integral
of the activity in the source organ. The total target organ dose is the summation of all
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source organ contributions. The activity in each source organ at different time-points is
determined from regions of interest on the geometric mean of a gamma camera whole
body anterior and posterior conjugate opposite views. Radionuclide S values have been
derived from MC simulation of radiation transport in standard anthropomorphic models
and assuming a uniform organ activity distribution.
Although the value of MIRD fornmalism for calculating average internal doses in nuclear
medicine diagnostic studies, this model has three major conceptual limitations to be used
in internal radiotherapy treatment planning. The first limitation is that tumor and
metastases, which uptake a significant amount of the radiophamaceutical, are not
included in the model. Second, the MIRD standard anatomic models do not fit the real
dimensions and morphology of each patient. The critical effect of organ morphology and
sizes in dosimetry calculations has been demonstrated by several studies (Clairand et al.,
2000; Breitz, 2002). The third limitation is the assumption of uniform activity and dose in
organs does not allow considering the dosimetry effect of cold spots on the tumor and hot
spots in normal organs. It is known that the non-uniform distribution of therapeutic dose
significantly affects the regression/ablation in the case of tumors and the radiotoxicity of
normal tissues (Furhang et al., 1997).
In addition absorbed dose delivered by beta particles is calculated by assuming local
absorption at the source organs and no consideration is given to the range of beta
particles. Attempt to adapt the MIRD formalism to a more patient-specific approach have
included the simulation of tumors by MIRD standard organs (Leichner and Kwok, 1993),
estimation of tumor volume by CT and use of S sphere values (Wessels et al., 1990), and
the MABDOSE (Johnson et al., 1999a; 1999b) and DOSE3D formalisms including
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spherical tumors, MC dose calculations and more flexibility in organ sizes and locations.
However, the basic limitations of standard anatomic geometries and uniform organ
activity and dose remain in all these approaches.
In addition to the conceptual limitations described above, the quantization of the whole
body anterior and posterior views required for the MIRD formalism is affected by
significant experimental errors, such as the attenuation and scattering of photons, tissue
background subtraction, overlapping of organs, lack of organ visualization in one of the
views and no information on organ masses. All these errors and model limitations make
the inaccuracy of MIRD calculations.
1.4 Significance of the Problem
At present, two methods can satisfy patient-specific dosimetry requirements for internal
radiotherapy. These methods are the Monte Carlo simulation of radiation transport based
dosimetry and the 3D convolution of the cumulative activity with a dose-point kernel
radial function. MC main drawback is the extended computational time, these are time-
intensive computations.
Dose-point kernels are radially symmetric functions representing the absorbed dose in a
target point per radioactive decay in a source point. These functions have been generated
for Monte Carlo radiation transport simulations for an unbounded homogeneous medium,
usually water (Cross et al., 1992; Furhang et al., 1996) and represented by analytical
functions for beta (Preswitch et al., 1989) and gamma emissions (Furhang et al., 1996).
The cumulative activity to be convolved is derived from the SPECT or PET slices (Erdi
et al., 1998). The main problem of the convolution is that is difficult incorporating tissue
5
inhomogenities since the voxel S values can only be generated assuming an infinite,
homogeneous medium. A second difficulty is the election of the grid size and how to
define the source and the target. Nuclear image data are acquired in a coarse matrix and
there is not much sense to carry out the dose calculations on such a fine scale. The voxel
source kernel is the method that considers the experimental limit of resolution at which
nuclear images are acquired and reconstructed.
The overall goal of this project is improved patient-specific radiotherapy planning using
internal emitters. To accomplish this goal, an internal dosimetry calculation protocol
based on hybrid SPECT/CT images, Monte Carlo simulation and a dose-voxel kernel
convolution method will be developed, validated and implemented as a software toolbox
for its clinical and research use.
One current limitation of dosimetry calculations at the voxel level using the convolution
method is the lack of voxel S values for different radionuclides and voxel sizes.
1.5 Main Goals and Objectives
To develop algorithms and software tools for 3D absorbed dose distributions using
emission and transmission images.
For accomplishing these objectives and to compensate the lack of S values, we developed
and implemented, a simple algorithm for determining voxel S values based on the Monte
Carlo integration of dose-point kernels on cubical source-target geometry in C++
Software.
And these Results were compared with those of the Bolch method.
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2. BACKGROUND
Radionuclides are administered to patients in nuclear medicine procedures in a variety of
diagnostic and therapeutic applications. A key consideration in such studies is the
absorbed dose to different organs of the patient; this concern is naturally heightened in
therapy applications, where a significant absorbed dose may be received by other organs
and in particular by radiosensitive organs. Absorbed doses are calculated with the aid of
anthropomorphic phantoms, i.e. mathematical representations of the human body, which
provide the absorbed fractions and organ nasses. A valid internal dose estimate depends
heavily on the collection of kinetic data for organs which concentrate the
radiopharmaceutical (source organs), the whole body and for all excretion pathways.
Obtaining these data require the proper measurement methods and acquisition of data at
appropriate time points. The information obtained in a dosimetry study is used in many
different ways, including evaluation of individual trials, and in the approval of
radioactive drugs for general use. Radiation dose estimates for individual organs, usually
for the two or three organs receiving the highest dose, and the EDE (effective dose
equivalent) or ED (equivalent dose), in the case of diagnostic studies, are used to evaluate
the radiation dose expected to be received, and thus the maximum amount of activity that
should be administered. Obviously in therapeutic situations, the evaluation is more
important, as the radiation dose received is much higher. For many years the Medical
Internal Radiation Dose (MIRD) method has been used for calculating diagnostic doses.
The MIRD committee of the Society of Nuclear Medicine provides a general framework
for the dosimetry of administered radiopharmaceuticals.
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2.1 Internal dosimetry methods
2.1.1 Basic concepts
A generic equation for the absorbed dose in an organ is:
kA j niEip
Where
D=absorbed dose (rad or Gy);
A=cumulated activity (KCi h or MBq s);
n,=number of particles with energy Ej emitted per nuclear transition;
E,energy per particle (MeV);
f=fraction of energy absorbed in the target;
m=mass of target region (g or kg) and
k=proportionality constant (rad g/PCi h MeV or Gy kg/MBq s MeV).
The term "cumulated activity" (A) is given to the area under the time-activity curve for a
source organ or region. As activity is the number of disintegrations per unit time,
integrating this over time gives the total number of disintegrations.
2.1.2 The IIRD Formulation
The Medical Internal Radiation Dose (MIRD) Committee of the Society of Nuclear
Medicine has provided guidance on methods for calculating radiation absorbed dose
estimates since 1968 (Watson and Stabin, 1993). By definition, the absorbed dose is the
energy absorbed from ionizing radiation per unit mass of tissue. Because absorbed dose
from internally distributed radionuclides is never completely uniform (Loevinger and
8
Watson, 1988) the MIRD equations give the average, or mean, absorbed dose to a
volume of tissue.
The schema is useful for estimating absorbed dose to volumes as small as a cluster of
cells or as large as the total body. Microdosimetric techniques that account for statistical
aspects of particle' track structures and energy distribution patterns in microscopic
volumes can be used to express energy deposition in tissues from materials labeled with
alpha-particle or Auger-electron emitters, particularly those incorporated within cells.
The equation for absorbed dose in the Medical Internal Radiation Dose (MIRD) system
(Watson, 1988) is a deceptively simple representation of above equation:
D)= AS Eq.1
The cumulated activity is defined above, while all other terms are lumped in the factor S:
In the MIRD equation, the factor k traditionally applied is 2.13, which gives absorbed
dose in rad, from activity in Ci, mass in g and energy in MeV. With more applications
currently employing the SI unit system, a factor relating absorbed dose in Gy from
activity in Bq and energy in MeV may be derived and employed.
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The total mean absorbed dose in a target region is calculated by summing the doses from
all source regions to the target. Equation (1) can be divided into two types of parameters-
physical and biological.
In any real internal dose problem, there will be more than one organ, which concentrates
the activity, and many targets for which the absorbed dose is required. In this case, the
MIRD equation needs to be solved for each source region (rh) and target region (rk) as
follows:
D, = AS(rk -- r")
h
If the area under the time-activity curve for a source organ (cumulated activity) is
normalized to the amount of activity administered (Ao), this is defined as "residence
time" (Watson, 1988).
Ah
TI
Using this definition the dose equation may be written as:
h
Values of cumulated activity (A) or residence time (r) must be developed for those
organs where the activity concentrates (e.g. liver, kidneys, spleen, thyroid), the organs
involved in excretion of the compound from the body (e.g. urinary bladder, intestines)
and the remainder of the body. Then, the absorbed dose is calculated by multiplying the
values of A (or r) by the appropriate S values. The software package MABDOSE
(Johnson, 1988) performs dose calculations, with the possible inclusion of tumor source
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regions, and integration of organ time-activity curves(the MIRDOSE software requires
that the user perform these integrations separately).
2.2 Absorbed dose calculation
2.2.1 MIRD S values
For homogeneous activity distribution in organs, MIRD S values (Watson, 1988) have
been used in both diagnostic and therapy absorbed dose calculations. Program packages
(Johnson 1988) have been proposed; and the inclusion of tumors is possible. The largest
single source of error in the procedure is often in the biokinetics, especially the
uncertainty in the late activity-time data. However, in situations in which the mass of the
target region is difficult to determine, this may introduce the largest source of error. The
use of S values based on standardized individuals, even if scaled using the true organ
mass from patient-specific data, may also introduce significant errors into the analysis
(Sgouros et. al., 1997). If the activity distribution is relatively uniform within the organ,
the standard approximations may be relatively good, but if there are important in
homogeneities (the presence of a hot or cold tumor, etc.), calculations based on the
assumption of a uniform activity distribution may be significantly in error.
2.3 Patient - Specific Dosimetry
2.3.1 Motivation for patient-specific dosimetry
Radionuclide therapy based on patient-specific dosimetry offers the potential for
optimizing the dose delivered to the target tumor through utilization of measured
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radiopharmaceutical kinetics specific to the individual. The administered activity may be
tailored for the patient such that the highest possible radiation dose may be given to the
tumor while limiting the dose to critical organs and tissues below any designated
threshold for negative biological effects. A pretreatment quantitative dosimetry work-up
using diagnostic ("tracer") activities of the therapy radiopharmaceutical serves also to
identify those cancer patients for whom the treatment is likely to be most effective while
eliminating those for whom it would be unsuccessful. In the case of radio
immunotherapy, these considerations are of particular importance in that the low uptake
in tumor regions (low target to non-target uptake ratios) may constrain the treatment
protocol (Erdi and Wessels 1996).
2.3.2 Activity Quantitation (Introduction to SPECT/CT):
With SPECT systems, simultaneous transmission-emission studies can be made with
exact registration, but the spatial resolution characteristic of SPECT allows visualization
only of major features such as organ outlines and lung regions. In many patient situations,
a conventional CT study is routinely made prior to radionuclide therapy. Effective image
registration techniques can be applied to take advantage of these anatomical images for
the attenuation correction and for the 3D absorbed dose calculation. Potential problems
include the fact that the CT data are obtained from X-ray spectra, thus the transformation
of pixel values to attenuation coefficients and density values may not be straightforward.
Furthermore, the registration of SPECT/CT images is more complex in the abdomen,
where translational and rotational effects may occur.
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Medical diagnoses commonly rely on assessment of a patient's functional status and
physical condition, and there are superb imaging modalities capable of providing that
information-within certain parameters. Radionuclide-tracer techniques such as positron-
emission tomography (PET) and single-photon-emission computed tomography
(SPECT) provide functional information, but have relatively poor spatial resolution and
can lack the anatomical information needed to localize or stage disease.
CT, on the other hand, offers excellent spatial resolution and rich anatomical detail.
Integrating the two on a common gantry and patient table, in a concept that has only
recently been brought to the commercial marketplace, holds the promise of simplifying
patient handling, data acquisition, and co registration of the CT and radionuclide image
data. SPECT/CT and PET/CT operate on the same basic design principle: the dual
modality acquires CT and radionuclide scans by translating the patient from one detector
to the other while the patient remains on the table. This allows both images to be taken
with consistent scanner geometry and with minimal delay between the two acquisitions.
After both sets of images have been acquired and reconstructed, image-registration
software fuses the images while accounting for differences in scanner geometry and
image format between the two data sets. One of the major anticipated uses of SPECT/CT
is the production of better attenuation correction. The results of both studies are available
on the same day, so the pathology and the patient's medical condition obviously have not
changed. Combined technology helps because it produces the result right away, with the
appropriate technical subtleties. An additional benefit of SPECT/CT is its ability to
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quantitate blood flow in an absolute sense, which is important for the better detection of
global balanced ischemia.
PET/CT also has the advantage of shortening overall examination time, thereby
increasing throughput in the imaging center; a PET/CT fusion scanner can often image up
to 16 cases per day.
2.4 Absorbed Dose Calculation Methods for Patient Specific Dosimetry
2.4.1 Dose point kernels
For infinite and homogeneous media, the dose point kernel (DPK) method can be used
and also for an inhomogeneous activity distribution in a homogeneous material
(regarding both elemental composition and density), a dose point kernel may be used
(Berger, 1973; Prestwitch, 1989; Simpkin, 1990; Leichner, 1994). The DPK method
could be applied for the situations involving finite and/or heterogeneous media by
rescaling the DPKs, in spite of possible error in the dose estimation. Treatment planning
systems, based on dose point kernels, had been reported by several authors (Sgouros,
1993; Giap, 1994; Akabani, 1997). The conversion of activity to absorbed dose can be
regarded as a filtering method, either as a convolution process in the spatial domain or as
a multiplication in the frequency domain. When applied in the spatial domain, rescaling
of the kernel distribution can be done when crossing a boundary. Applying the kernel in
the frequency domain is often implemented to speed up the calculations.
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2.4.2 Monte Carlo simulation
The major limitation with dose kernels is that they can only describe the distribution in a
uniform infinite medium. This affects the accuracy in the calculation of the dose
distribution at interfaces between different attenuating media (such as between lung
tissue and muscle tissue). The most accurate method is therefore to fully model the
interaction of photons and electrons from a patient-specific activity distribution and
attenuation map using a Monte Carlo transport method (Raeside, 1976).
In a treatment planning system, based on quantitative SPECT and Monte Carlo, the
emission of photons and electrons are simulated and their paths are followed, using
probability functions to govern their loss of energy, deflection/scattering angles and other
events, as they pass through the system. Performing transport of all emitted particles and
their secondary particles can account for in homogeneities, both in activity, elemental
composition, and density.
Public domain Monte Carlo packages, such as EGS4 (Simpkin, 1990), MCNP and ITS
(Briesmeister, 1993), are available and may be implemented in radionuclide treatment
planning. More dedicated treatment planning programs, based on Monte Carlo
simulations, have been reported (Furhang, 1997). Such systems use quantitative planar-
or SPECT images to establish the biokinetics of the radiopharmaceutical and the activity
distribution. Information about the size, shape and mass of the organs may be obtained
from these data by, for example, segmentation methods. The information derived from
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these sequential images provides the activity as a function of time, which can, as
discussed above, be used to calculate the absorbed dose rate as a function of time and
location within the subject. The dose rate is then integrated to obtain the cumulative dose
to individual organs, regions, etc. These data may be analyzed as an absorbed dose
distribution, in terms of total absorbed dose to different regions, dose-volume histograms,
etc., with the hope that such information will provide a more comprehensive evaluation
of the therapy effect.
2.4.3 S Voxel kernel method
The main drawback of the Monte Carlo method is its extended computational time. A
second problem with a Monte Carlo simulation is that the surface of the organs described
in Monte Carlo code is usually required to be in analytical form; ex., sphere, cylinder,
plane, or a volume composed by the intersection of those surfaces. Thus, it is difficult to
use CT 3-D anatomy in any Mote Carlo calculation without assuming crude
approximations. In an attempt to make computations both patient-specific and real-time,
we have developed an alternative method based on a voxel source kernel ie. S Voxel
kernel method. Average absorbed dose to each voxel in the 3-D patient volume was then
estimated by convolving the S voxel kernel method with the 3-D matrix of organ uptakes.
A uniform activity concentration in each organ was obtained by dividing cumulated
activity by the total number of voxels in that organ. Next, the average dose in each organ
was calculated by averaging the doses in all the voxels within the organ. Statistical
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information, such as standard deviation of the average dose in each organ as well as the
dose-volume histogram, was also obtained.
Notice that, although uniform activity distribution within each organ was initially
assumed in our calculation, this was not a limitation in the S voxel kernel method itself. If
the no uniform distribution of radioactivity was known, it could be incorporated into the
method by using a radioactivity concentration lookup table. Furthermore, if a tumor is
visible in a patient CT scan, tumor volumes can be obtained by drawing a boundary
around the lesion. Given this volume, the activity concentration within the tumor can be
determined using the CAMI (CT -assisted matrix inversion method) bed dose to tumor
can be estimated by the S voxel kernel method.
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3. MATERIALS AND METHODS
3.1 Calculation of Svoxel Values:
Voxel S values could be calculated from the six-dimensional numerical integration of
dose-point kernels over the source and target voxels or by the convolution of dose point-
kernels with the geometrical factor of the source-target voxel geometry. In this research S
values are calculated, based on the Monte Carlo volume integration of tabulated dose
point-kernels of beta emissions over a voxel-to- voxel geometry.
The method has been implemented in C++ Program (Windows NT) and this method
calculates beta S values from the dose point-kernels tabulated by Cross (Cross et. al.,
1992) and any cubical or non-cubical voxel dimensions in a water medium. Results of
calculations were verified by comparing voxel S values of four radionuclides and three
voxel sizes with those reported by Bolch (Bolch et. al., 1999) using the EGS4 code for
Monte Carlo radiation transport simulation.
Beta dose point-kernels in water were derived from the tables of Cross (Cross et. al.,
1992) are stored as a lookup table for each radionuclide. The units used for dose rate in
Cross are nGy/Bq-h, so dose point-kernel data of Cross were multiplied by 0.0002778 to
convert the dose rate from nGy/Bq-h to mGy/MBq-s.
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Lookup Table for Radionuclide Y90
First column represents distance in mm and second column in the table represents dose-
point kernels in nGy/Bq-h.
data: 29
0.000, 104.0
0.008, 99.60
0.016, 99.20
0.024, 98.90
0.032, 98.60
0.040, 98.30
0.080, 96.40
0.120, 93.50
0.160, 89.70
0.200, 85.10
0.240, 79.60
0.280, 73.60
0.320, 67.10
0.360, 60.40
0.400, 53.50
0.440, 46.60
0.480, 39.70
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3.2 Target and Source voxels: The centroid of the source voxel was considered as
(0,0,0) and the centroid of the target voxel as (x, y, z) where these values are the distance
in mm between the centroids of the source and target voxels for each axis.
3.3 Random points in Source and Target voxel: For each pair of source and target
voxels, a number of rays were simulated between random points (xs, vs, zs) within the
source voxel and random points (x,, yt, zt) within the target voxel. Random points within
the source and target voxels were determined by using Random Numbers as:
Xs = (Ax/2). RND (1)
Ys = (Ay/2). RND (2)
Zs = (Az/2). RND (3),
Xt = x + (Ax/2). RND (4)
Yt = y + (Ay/2). RND (5)
Zt = z + (Az/2). RND (6),
where Ax, Ay and Az are the edge dimensions of the cubical or non-cubical voxel, and
RND(*) is a random number uniformly distributed between -1 and +1.
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3.4 Explanation of Random number generations Program:
The function rand ( ) generates random numbers from 0 to 65534, where 65534 is the
maximum random number. But as a part of this research work, the generation of random
numbers from -1 to +1 is necessitated. Hence the modified program given above, meets
the specified needs. In this program, first the random values from 0 to 65534 have been
generated and then checked for a condition, i.e., if the random value is greater than 1 then
it is divided by RAND_MAX. By doing this we can get random numbers from 0 to 1.
And now for generating random numbers from -1 to 0, we generate two random numbers
randNum1 and randNum2 and one integer randPow. Where
randPow= randNum* 10
Now this randPow gives only single digit random numbers (ex, 3,7,6,9,2,1...) as this
integer is multiplied by 10.
randNum 1 = pow (-1,randPow)*randNum2
pow(-1,randPow) generates the random signs (+ve or -ve)
Sign is assigned to random numbers generated by randNum2 variable by multiplying
with pow (-1,randPow) and are stored in randNum 1.
3.5 Diagram to check Random Numbers between -1 and +1:
The random numbers generated were plotted in excel graph and the mean and standard
deviation were calculated. The mean value is zero and we can say that the random
numbers generated were in between -1 and +1. And the standard deviation is 0.5.
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Diagram to check the random numbers between -1 and +1
randomnumbers
15
s
h
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3.6. Linear logarithmic Interpolation:
At the position (0,0,0) the target voxel was the same as source voxel. No dose calculation
was performed if source and target random points become the same at voxel (0,0,0).
The absorbed dose per decay, expressed in mGy/MBq-s, was calculated for each
distance between (xs, ys, z,) and (xt, yt, zt) by logarithmic-linear interpolation of the dose
point-kernel data in the lookup table. Dose point-kernel data of Corss were multiplied by
0.0002778 to convert dose rate from nGy/MBq-s.
Equation for Logarithmic Interpolation :
log[r (i)]-log[r (i+1)] (d, - di+,)
log[r (i)]-log [Y] (di - X)
Where r (i) and r (i+1) are the values of dose rate in nGy/Bq-h derived from Bolch table
Di and d;+1 are the distances in cm from Bolch table X is the distance which lies between
the distances in the table Y is the value of dose rate at distance X.
3.7 Calculation of Svalues:
First the radionulide file is read and is stored as lookup table in the program. Then the
voxel file is also read, which has pixel dimensions and also maximum values of the
centroids of target voxels in positive octant and also the number of simulations.
Depending on the centroids and no. of simulations the voxel S values are calculated from
the lookup table. Voxel S values were calculated as the average of all absorbed doses per
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decay. One million rays were simulated for each source-target voxel pair. After one
million of simulations, there was no reduction in the relative standard deviation
(STD/average) of voxel S values. Results of one million or more simulations were also
closer to those of Bolch (Bolch et. al., 1999). Ten million rays were simulated in the case
of low energy emissions to improve the statistical uncertainty of the dose. Since the radial
symmetry of dose point-kemel, voxel S values were only calculated in the positive
octant. The voxel Svalues lower than 0.01% of the voxel S values at (0,0,0) were
discarded. The average of one million Svalues is calculated for all distances and for all
coordinates.
The distance between the source and target random points is calculated by:
D= (X$- s)+(Y- s)+(Zt-Zs)
The distances, which are very less, are neglected. When the distance lies between the
values in the Bolch table then the dose point kernel for that distance is calculated by
using Interpolation method. The formula for Interpolation is given as:
Yx = (log[r (i)]-log[r (i+l)]) * (di - X)/ (d; - di.j)
Sx2 = exp (log[r (i)]-Yx)
Svoxel = Sx'/ D*D
Svoxel = Svoxel * 0.0002778
Stotal = Stotal+Svoxel
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Saverge = Stotal/number of simulations
Where r(i) and r(i+1) are the values of dose rate in nGy/Bq-h derived from Bolch table
X is the distance, which we need
Yx is the value of dose rate at distance X.
Svoxel is the absorbed dose calculated from Logarithmic Interpolation
Stotal is the total of all absorbed doses for one million simulations
Saverage is the average of all absorbed doses.
3.7 Flowchart of Complete Program
Radionuclide
File
Computer Output File
Voxel File
3.8 Inputs in program
To run the program the user must input the radionuclide, voxel dimension and the
number of simulations.
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There are two input files in this program: 1) Radionuclide file 2) VoxeI file
Radionuclide File: Y90
Radionuclide file has beta dose-point kernels in water for different distances which are
derived from the tables of Cross (Cross et al., 1992).
It had two columns, the first represents the distance in mm and the second one represents
dose-point kernel values in nGy/Bq-h
data: 29
0.000, 104.0
0.008, 99.60
0.016, 99.20
0.024, 98.90
0.032, 98.60
0.040, 98.30
0.080, 96.40
0.120, 93.50
0.160, 89.70
Voxel File
The other input file ie. the voxel file has pixel dimensions and also maximum values of
the centroids of target voxels in positive octant and number of simulations.
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The voxel sizes are in cm.
xpixel: 0.3
ypixel: 0.3
zpixel: 0.3
simulations: 10000000
Max xposition: 6
Max yposition: 6
Max zposition: 6
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3.8.1 Program Output
The program output is a text file. It includes voxel S values for the set of coordinates in
the first octant,
Output File:
Radionuclide: Y90.dat
X:3
Y: 3
Z: 3
Xsize: 0.300000
Ysize: 0.300000
Zsize: 0.300000
000: 1.612986
100: 0.282232
200: 0.021710
This program can be used to calculate voxel S values of beta emissions from tabulated
dose-point kernels and for any combination of pixel edges and thickness of SPECT and
PET images without the complexity and expertise needed for direct Monte Carlo
radiation transport simulations. Total time of calculation is from 5 to 60 minutes,
depending on voxel dimensions, no. of simulations and radionuclide.
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3.9FlowChart.
INPUT
Voxel file(xpixel,y pixel,z
RadioNuclide pixelNumberOfRaysMax
F x,Maxy and Maxz
r2J[ ] = r2J[ ] * 00002778
Generate Random Numbers
Calculate Calculate
L xsource,ysource,zsource xtargetytargetztarget -
Calculate distance between source and target
r[i]>Distance
<r[i+1]
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Calculate S value using
logarithmic interpolation
S valueS value/distancexdistance
S value>0.001xS
value
Calculate Average S value
Maxx,MaxyMaxz,xpixel,ypixelzPixe
Avg S value
And these values are compared with that of the Botch Method by calculating the
percentage difference in both methods.
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4. RESULTS
Isotopes: Cu-64, Cu-67, 1-125, 1-131, In-111, P-32, Re-186, Re-188, Sr-89, Y-9
Pixel Size: 1 mm
Svalues in mGy/MBq-s.
distance
xyz (mm) Cu-64 Cu-67 1-125 1-131 In-111
000 0.00 11.009109 16.6778 0.650181 16.9651 3.159351
001 1.00 1.037525 0.97515 1.521666 0.168921
011 1.41 0.191359 0.112997 0.259719 0.010566
111 1.73 0.045394 0.017664 0.05748 0.000738
002 2.00 0.007272 0.007974
012 2.24 0.002089 0.002182
211 2.45
220 2.83
221 3.00
222 3.16
300 3.00
310 3.16
311 3.32
distance
xyz (mm) P-32 Re-1 86 Re-188 Sr-89 Y-90
0 0.00 4.023276 19.73106 16.98634 16.71453 15.35531
100 1.00 0.706466 2.654223 3.223802 3.17959 3.173595
110 1.41 0.247988 0.808911 1.41814 1.333232 1.444692
111 1.73 0.113397 0.342775 0.852372 0.76223 0.889774
200 2.00 0.055137 0.156632 0.577127 0.489365 0.618016
210 2.24 0.030619 0.085181 0.433226 0.350555 0.47482
211 2.45 0.017331 0.04775 0.338301 0.26048 0.379715
220 2.83 0.005578 0.015489 0.222442 0.153994 0.262015
221 3.00 0.00318 0.009051 0.185499 0.121319 0.223791
222 3.16 0.00054 0.114786 0.062347 0.148844
300 3.00 0.003019 0.0086 0.184792 0.120718 0.223139
310 3.16 0.001705 0.005043 0.156171 0.096166 0.193143
311 3.32 0.000948 0.002946 0.133267 0.077166 0.16879
Table 1. Voxel S values (mGy/MBq.s) of cubical voxels of 1 mm on edge.
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Isotopes: Cu-64, Cu-67, 1-125, 1-131, In-ill P-32, Re-186, Re-188, Sr-89, Y-9
Pixel Size: 2 mm
Svalues in mGy/MBq-s.
distance
xyz (mm) Cu-64 Cu-67 1-125 1-131 In-111
000 0.00 1.721667 2.654138 0.128429 2.724808 0.457736
001 2.00 0.092957 0.074754 0.133991
011 2.83 0.007769 0.004088 0.010257
111 347 0.000782 0.00027 0.000952
002 4.00
012 4.47
211 4.90
220 5.66
221 6.00
222 6.33
300 6.00
310 6.33
311 6.63
distance
xyz mm) P-32 Re-186 Re-188 Sr-89 Y-90
0 0.00 4.00025 3.790772 4.007126 3.893965 3.76913
100 2.00 0.70643 0.336128 0.694345 0.618123 0.726269
110 2.83 0.248216 0.056258 0.262648 0.199626 0.298646
111 3.47 0.113491 0.011954 0.13309 0.083915 0.165006
200 4.00 0.055152 0.001388 0.074108 0.036309 0.101215
210 4.47 0.030624 0.04666 0.018156 0.069196
211 4.90 0.01734 0.030303 0.009127 0.048883
220 5.66 0.005574 0.013447 0.002172 0.025713
221 6.00 0.003178 0.009133 0.001049 0.019
222 6.33 0.000539 0.002892 0.007781
300 6.00 0.003019 0.008985 0.000919 0.01883
310 6.33 0.001705 0.006132 0.000428 0.013998
311 6.63 0.000949 0.004198 0.010421
Table 11. Voxel S values (moy/MBq.s) of cubical voxels of 2 mm on edge.
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Isotopes: Cu-64, Cu-67, 1-125, 1-131, In-111, P-32, Re-186, Re-188, Sr-89, Y-90
Pixel Size: 3 mm
Svalues in mGy/MTq-s.
distance
xyz (mm) Cu-64 Cu-67 1-125 1-131 n-111
000 0.00 0.590493 0.772997 0.045001 0.911906 0.142114
001 3.00 0.020665 0.02909
011 4.24 0.001123 0.001436
111 5.20 0.000067
002 6.00
012 6.71
112 7.35
022 8.49
003 9.00
013 9.49
113 9.95
221 9.00
distance
xyz (mm) P-32 Re-186 Re-188 Sr-89 Y-90
000 0.00 1.660587 1.32593 1.652983 1.618985 1.612986
001 3.00 0.239203 0.082815 0.250747 0.197784 0.282232
011 4.24 0.061359 0.008766 0.07571 0.044614 0.098632
111 5.20 0.019515 0.001111 0.029632 0.01223 0.045009
002 6.00 0.005448 0.011737 0.002472 0.02171
012 6.71 0.00199 0.005556 0.000739 0.011849
112 7.35 0.000715 0.002644 0.000214 0.006514
022 8.49 0.000563 0.001913
003 9.00 0.00026 0.000957
013 9.49 0.000217 0.000501
113 9.95 0.000255
221 9.00 0.001028
Table Ill. Voxel S values (mGy/MBq.s) of cubical voxels of 3 mm on edge.
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Isotopes: Cu-64, Cu-67, 1-125, In-111, P-32, Re-186, Re-188, Sr-89, Y-90
Pixel Size: 4 mm
Svalues in mGy/MBq-s.
distance
xyz (mm) Cu-64 Cu-67 1-125 In-Ill
000 0.00 11.009109 0.000313 0.128429 0.000675
001 4.00 1.037525
011 5.65 0.191359
111 6.93 0.045394
002 8.00 0.007272
012 8.95 0.002089
211 9.80
220 11.32
221 12.00
222 12.65
300 12.00
310 12.65
311 13.27
distance
xyz (mm) P-32 Re-186 Re-188 Sr-89 Y-90
0 0.00 0.001579 0.000718 0.001686 0.001285 0.00198
100 4.00
110 5.65
111 6.93
200 8.00
210 8.95
211 9.80
220 11.32
221 12.00
222 12.65
300 12.00
310 12.65
311 13.27
Table IV. Voxel S values (mGy/MBq.s) of cubical voxels of 4 mm on edge.
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Isotopes: Cu-64, Cu-67, -131, In-111, P-32, Re-186, Re-188, Sr-89, Y-90
Pixel Size: 5 mm
Svalues in mGy/MBq-s.
distance
xyz (mm) Cu-64 Cu-67 1-131 In-111
000 0.00 0.000127 0.0004 0.0003 0.000032
001 5.00
011 7.07
111 8.67
002 10.00
012 11.18
211 12.25
220 14.15
221 15.00
222 15.82
300 15.00
310 15.82
311 16.58
distance
xyz (mm) P-32 Re-186 Re-188 Sr-89 Y-90
0 0.00 0.000852 0.000339 0.000927 0.000654 0.001123
100 5.00
110 7.07
111 8.67
200 10.00
210 11.18
211 12.25
220 14.15
221 15.00
222 15.82
300 15.00
310 15.82
311 16.58
Table V. Voxel S values (mGy/MBq.s) of cubical voxels of 5mm on edge.
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Isotopes: Cu-64, Cu-67, 1-131, In-111, P-32, Re-186, Re-188, Sr-89, Y-90
Pixel Size: 6 mm
Svalues in mGy/MBq-s.
distance
xyz (m Cu-64 Cu-67 1-131 In-111
000 0.00 0.00006 0.000061 0.000111 0.000027
001 6.00
011 8.48
111 10.40
002 12.00
012 13.42
211 14.70
220 16.98
221 18.00
222 18.98
300 18.00
310 18.98
311 19.90
distance
xyz (mm) P-32 Re-186 Re-188 Sr-89 Y-90
0 0.00 0.000459 0.000207 0.000546 0.000379 0.000635
100 6.00
110 8.48
111 10.40
200 12.00
210 13.42
211 14.70
220 16.98
221 18.00
222 18.98
300 18.00
310 18.98
311 19.90
Table VI. Voxel S values (mGy/MBq.s) of cubical voxels of 6mm on edge.
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Isotopes: Cu-64, Cu-67, 1-125, 1-131, In-111, P-32, Re-186, Re-188, Sr-89, Y-9(
Pixel Size: 7 mm
Svalues in mGy/MBq-s.
distance
xyz (mm) Cu-64 Cu-67 1-125 1-131 In-111
000 0.00 0.000041 0.00002 0.650181 0.000075 0.000012
001 7.00
011 9.89
111 12.13
002 14.00
012 15.66
211 17.15
220 19.81
221 21.00
222 22.14
300 21.00
310 22.14
311 23.22
distance
xyz (mm) P-32 Re-186 Re-188 Sr-89 Y-90
0 0.00 0.00029 0.000107 0.000322 0.000259 0.000384
100 7.00
110 9.89
111 12.13
200 14.00
210 15.66
211 17.15
220 19.81
221 21.00
222 22.14
300 21.00
310 22.14
311 23.22
Table VII. Voxel S values (mGy/MBq.s) of cubical voxels of 7mm on edge.
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Distance is in mm
Svalues are in mGy/Mbq-s.
Radionuclide P32
Voxel Size 3mm
Voxel distance Monte Carlo Monte Carlo Radiation
Position mm Volume Integration Transport Simulation Diff (%)
000 0 1.64 1.65 0.61
001 3 0.239 0.232 2.89
011 4.24 0.061 0.062 1.21
111 5.2 0.0196 0.0212 7.74
002 6 0.00545 0.00678 19.62
012 6.71 0.00199 0.00288 30.94
112 7.35 0.00072 0.00124 41.69
Table VIlL Comparing Voxel S values of Radionuclide: P32 with Voxel size 3mm using
Monte Carlo Volume Integration (my method) and Monte Carlo Radiation Transport
Simulation (Bolch Method)
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Distance is in mm.
Svalues are in mGy/Mbq-s.
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Figure 1: Comparing Voxel S values of Radionuclide: P32 with Voxel size 3mm using
Monte Carlo Volume Integration (my method) and Monte Carlo Radiation Transport
Simulation (Bolch Method)
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Distance is in mm.
Svalues are in mGy/Mbq-s.
Radionuclide P32
Voxel Size 6mm
Voxel Distance Monte Carlo Monte Carlo Radiation
Position m Volume Integration Transport Simulation Diff (%)
000 0 0.31913 0.319 0,44
001 6 0.02512 0.0253 0.71
011 8.48 0.00286 0.00313 8.53
111 10.4 0.00038 0.00046 17.89
Table IX: Comparing Voxel S values of Radionuclide: P32 with Voxel size 6mm using
Monte Carlo Volume Integration (my method) and Monte Carlo Radiation Transport
Simulation (Bolch Method)
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Distance is in mm.
Svalues are in mGy/Mbq-s.
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Figure 2: Comparing Voxel S values of Radionuclide: P32 with Voxel size 6mm using
Monte Carlo Volume Integration (my method) and Monte Carlo Radiation Transport
Simulation (Boich Method)
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Distance is in mm.
Svalues are in mGy/Mbq-s.
Radionuclide Sr89
Voxel Size 3mm
Voxel distance Monte Carlo Monte CarloRadiation
Position mm VolumeIntegration TransportSimulation Diff (%)
000 0 1.5671 1.55 1.1
001 3 0.20118 0.193 4.24
011 4.24 0.04441 0.046 3.46
111 5.2 0.01215 0.014 13.22
002 6 0.00247 0.00362 31.66
012 6.71 0.00074 0.00142 47.75
112 7.35 0.00022 0.00059 63.08
Table X. Comparing Voxel Svalues of Rdionuclide: Sr 89 with voxel size 3 mm using
Monte Carlo Volume Integration and Monte Carlo Radiation Transport Simulation
method.
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Distance is in mm.
Svalues are in rnGy/Mbq-s.
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Figure 3: Comparing Voxel S values of Radionuclide: Sr89 with Voxel size 3mnm using
Monte Carlo Volume Integration (mny method) and Monte Carlo Radiation Transport
Simulation (Boich Method)
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Distance is in mrm,
Svalues are in mGy/Mbq-s.
Radionuclide Sr89
Voxel Size 6mm
Voxel Distance Monte Carlo Monte Carlo Radiation
Position mm Volume Integration Transport Simulation Diff (%)
000 0 0.2815 0.285 1.23
001 6 0.01917 0.0196 2.21
011 8.48 0.00191 0.00213 10.14
111 10.4 0.0002 0.00028 26.88
Table Xl: Comparing Voxel S values of Radionuclide: Sr89 with Voxel size 6mm using
Monte Carlo Volume Integration (my method) and Monte Carlo Radiation Transport
Simulation (Bolch Method)
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Distance is in mm.
Svalues are in mGy/Mbq-s.
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Monte Carlo Volume Integration (my method) and Monte Carlo Radiation Transport
Simulation (Bolch Method)
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Distance is in mm.
Svalues are in mGy/Mbq-s.
Radionuclide Y90
Voxel Size 3mm
Voxel distance Monte Carlo Monte Carlo Radiation
Position mm Volume Integration Transport Simulation iff
000 0 1.62 1.61 0.61
001 3 0.282 0.276 2.17
011 4.24 0.0988 0.0976 1.20
111 5.2 0.0450 0.0453 0.74
002 6 0.0218 0.0226 3.72
012 6.71 0.0118 0.0128 7.48
112 7.35 0.0065 0.0074 11.92
022 8.49 0.0019 0.0025 2263
003 9 0.0010 0.0013 27.02
013 9.49 0.0005 0.0008 34.51
113 12.8 0.0003 0.0004 39.53
Table X11: Comparing Voxel S values of Radionuclide: Y90 with Voxel size 3mm using
Monte Carlo Volume Integration (my method) and Monte Carlo Radiation Transport
Simulation (Bolch Method)
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Distance is in mm.
Svalues are in mGy/Mbq-s.
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Figure 5: Comparing Voxel S values of Radionuclide: Y90 with Voxel size 3mnm using
Monte Carlo Volume Integration (my method) and Monte Carlo Radiation Transport
Simulation (Bolch Method)
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Distance is in mm.
Svalues are in mGy/Mbq-s.
Radionuclide Y90
Voxel Size 6mm
Voxel distance Monte Carlo Monte Carlo Radiation
Position mm Volume Integration Transport Simulation Diff (%)
000 0 0.34995 0.346 1.14
011 6 0.03934 0.0395 0.42
111 8.48 0.00721 0.00757 4.78
002 10.4 0.00154 0.00174 11.61
Table X111: Comparing Voxel S values of Radionuclide: Y90 with Voxel size 6mm using
Monte Carlo Volume Integration (my method) and Monte Carlo Radiation Transport
Simulation (Bolch Method)
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Distance is in mm.
Svalues are in mGy/Mbq-s.
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Figure 6: Comparing Voxel S values of Radionuclide: Y90 with Voxel size 6mm using
Monte Carlo Volume Integration (my method) and Monte Carlo Radiation Transport
Simulation (Bolch Method)
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5. DISCUSSION AND CONCLUSIONS
5.1 Discussion
Tables I to VI show the software output for 10 radionuclides of interest in internal
radiotherapy and cubical voxels 1mm, 2mm, 3mm, 4mm, 5mm, 6mm and 7 m on edge,
respectively. Distance in mm (Tables I to VI) corresponds to the distance between the
source and target voxel centroids. In Tables I to VII, xyz represents the coordinates of the
centroids of target voxels in the positive octant expressed as units of distance between the
source and target voxel centroids. Tables III and IV compare our results with those of
(Bolch et al., 1999) who calculated voxel S values using the EGS4 code for direct Monte
Carlo radiation transport simulation.
The comparison demonstrates a small percent difference between the two independent
methods. At larger distances from the source voxel, percent differences are larger. One
reason is because the Monte Carlo radiation transport simulation code included the dose
produced by bremsstrahlung photons beyond the CSDA range of the beta emissions
(Bolch. Et.al., 1999). Other additional reasons are the increased statistical uncertainty of
dose calculations by both methods at large distances from the source (lower number of
simulated rays) and different algorithms for simulation of radiation transport and energy
deposition (Bolch et.al., 1999; Cross et.al., 1992). While Bolch et al (Bolch. Et.al., 1999)
used the PRESTA algorithms for direct Monte Carlo simulations in tissue and calculate
the electron dose to distances approximating the CSDA range of the electron energy, the
dose-point kernels of Cross (Cross et.al., 1992) were calculated in water using the
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ACCEPT code with a cut-off energy of 2 keV or somewhat more for high initial energies.
However, at those larger distances from the source voxel the contribution to the absorbed
dose can be considered negligible. Since direct Monte Carlo radiation transport
simulation is considered the theoretical gold standard for radiation dosimetry, Tables III
and IV show the validity of our algorithm.
The Monte Carlo volume integration of dose point-kernels presented in this report has
been already suggested by Bolch (Bolch et.al., 1999). Our contribution has been to
implement a valid algorithm in computationally efficient software and verify the
accuracy of calculations by comparing our results with those determined by direct Monte
Carlo radiation transport simulation. The software can be used by any laboratory to
calculate voxel S values of beta emissions from tabulated dose point-kernels and for any
combination of pixel edges and thickness of SPECT and PET images without the
complexity and expertise needed for direct Monte Carlo radiation transport simulations.
51
Conclusions:
* The comparison demonstrates a small percentage difference between the two
independent methods.
* When distance is less, the error in calculating dose is less than 10%.
* At larger distances from the source voxel, percentage differences are larger. But at
larger distances the dose rates are very less and those values are negligible.
* Though this method has error at large distances, it is useful to calculate
voxelSvalues for all cubical and non-cubical voxels and thickness and for all
coordinates of SPECT and PET images with less time and without the complexity
of direct Monte Carlo radiation transport simulations.
* This method is very fast and it takes minutes to run this program.
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APPENDICES
APPENDIX-I
Creation of Random Numbers: (Program)
#include<stdio.h>
#include<string.h>
#include<mat.h>
#include<stdlib.h>
#include<time.h>
double next-rand_num ();
double randomnoGenerator ();
void main()
{ int i;
FILE *fp;
time t curTime;
time (&curTime) ; //Get current time in milliseconds
srand (curTime) ; //Initialize the seed with current time
fp=fopen("randnum.txt","W");
for(i=;i<1 00000;i++)
{
fprintf(fp,"%0f\n",randomnoGenerator());
}
printf("%d",RAD_MAX);
double nextrand num ()
{
double retVal ;
retVal = 1.0*rand () ;
while (retVal > 1)
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{
retVal = reVal / RAND MAX ;
}
return reVal ;
}
double randomnoGenerator ()
{
double randNum, randNum2 ;
int randPow;
randNum = nextrandnun( ;
//randPow=pow(randNum ,2)* 10;
randPow=randNum* 10;
randNum2 = next rand num();
//if(randPow!=0)
{
randNum=pow(-1,randPow)*randNum2;
}
return (randNum);
}
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APPENDI-I
Calculation of Voxel Svalues (Program code to Calculate Svoxel Values)
#include<stdio.h>
#include<string.h>
#include<math.h>
#include<stdlib.h>
#include<time.h>
/*functions declarations*/
double next rand num ();
double randomnoGenerator ();
void main(){
/******reading radionuclide.dat file*******/
/*variables declarations*/
long NumberOfData;
double r[1 00],r2J[ 100],Xpixel,Ypixel,Zpixel,rdd;
char RadionuclideFile[20],newSfile[20],ch,temp[20];
int i,j,icord,jcord,kcord,n;
long NumberOfRays,MaxX,MaxY,MaxZ,Nx,Ny,Nz;
double xsource,ysource,zsource,xtarget,ytarget,ztarget,distance;
double Svalue,tableint,Stotal,Sooo;
int indice,SumRays,Rays;
FILE *fpl, *fp2, *fp3;
//Get current time in milliseconds
time t curTime ;
//Initialize the seed with current time
time (&curTime) ;
srand (curTime) ;
printf("enter the radionuclide.dat file eg:Cu64.dat\n");
scanf("%s",RadionuclideFile);
printf("enter the new S-file\n");
scanf("%s",newSfile);
fp I =fopen(RadionuclideFile,"r");
if(fp 1 ==NULL)
{
printf("\ncannot open file\n");
exit(l);
fseek(fp 1,5,0);
//the number of data points are read into a variable NumberOfData.
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fscanf(fpl,"%ld",&Numbergf ata);
//the values from the first and second column are read and stored in arrays r[] and
r2J[]
//respectively.
for(j=O;j<NumberOfData;j++)
{
i=O;
while((ch=fgetc(fp 1))!',')
{
temp[i]=ch;
i++;
}
rU]=atof(temp);
fscanf(fp 1,"%lf',&r2J[j]);
r2Jj]=r2J]*0.00 2778 ;
}
fclose(fp 1)
//***********reading data from voxel.data **/
fp2=fopen("voxel.dat","r");
if(fp2==NULL)
{
printf(" ncannot open file\n");
exit(1);
}
//the data read from the file are stored in the corresponding variables.
wile((ch=fgetc(fp2))!=':');
fscanf(fp2,"%lf',&Xpixel);
while((ch=fgetc(fp2)) !=':');
fscanf(fp2,"%lf',&Ypixel);
while((ch=fgetc(fp2))!=':');
fscanf(fp2,"%Ilf",&Zpixel);
while((ch=fgetc(fp2)) ! =':');
fscanf(fp2,"%fld",&Number{f ays);
while((ch=fgetc(fp2))!='':');
fscanf(fp2,"%ld",&MaxX);
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while((ch=fgetc(fp2))!=':');
fscanf(fp2,"% d",&MaxY);
while((ch=fgetc(fp2)) !=':'");
fscanf(fp2,"%ld",&MaxZ);
Nx=MaxX;
Ny=MaxY;
Nz=MaxZ;
for(i=1 ;i<Nx+1;i++)
{
if(r[NumberOfData-1 ]<Xpixel*(MaxX-I.5))
MaxX=MaxX-1;
}
for(i= 1 ;i<Ny+ 1 ;i++)
{
if(r[NumberOfData-1 ]<Ypixel*(MaxY-0.5))
MaxY=MaxY-1;
}
for(i=1 ;i<Nz+1 ;i++)
{
if(r[NumberOfData-1]<Zpixel*(MaxZ-.5))
MaxZ=MaxZ-1;
}
/*****writing distances into new S file*****/
fp3=fopen(newSfile,"w");
if(fp3==NULL)
{
printf("\ncannot open file\n");
exit(1);
}
fprintf(fp3,"%s%s\n","Radionuclide:",RadionuclideFile);
fprintf(fp3,"%s%i\n","X: ",MaxX);
fprintf(fp3,"%si\n","Y: ",MaxY);
fprintf(fp3,"%si\n","Z: ",MaxZ);
fprintf(fp3,"%s%lf\n","Xsize: ", Xpixel);
fprintf(fp3,"%s%l fn","Ysize: ", Ypixel);
fprintf(fp3,"%s%lf\n","Zsize: ", Zpixel);
for(kcord=0;kcord<MaxZ+ 1;kcord++)
{
if(r[NumberOfData- 1 ]>Zpixel*(kcord-0.5))
{
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for(jcordkcord;jcord<MaxY ;jcord++){
if(r[NumberOfData-1]>Ypixel*(jcord-0.5)){
for(icord jcord ;icord<MaxX+ I;icord++){
if(r[NumberOfData-
1 ]>Xpixel*(icord-.5))
Stotal=0.0;
Rays=O;
tableint=0.0;
Svalue=0.0;
SumRays=O;
for(n=0;n<NumberOfRays;n++) {
rdd=randomnoGenerator();
xsource=randomnoGenerator()*(Xpixel/ 2 .0);
ysource-randonoGenerator()*(Ypixel/ 2 .0);
zsource=randomnoGenerator()*(Zpixel/ 2 .0);
xtarget=randomnoGenerator()*(Xpixel/ 2 .0);
ytarget=randomnoGenerator()*(Ypixel/ 2 .0);
ztarget=randomnoGenerator()*(Zpixel/ 2 .);
xtarget=icord*(Xpixel)+xtarget;
ytarget jcord*(Ypixel)+ytarget;
ztarget=kcord*(Zpixel)+ztarget;
distance=pow(xsource-xtarget,2.0)+pow(ysource-ytarget, 2 .)+pow(zsource-
ztarget,2.0);
distance=pow(distance,0.5);
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if(distance<r[ 1]/100.0)
distance=r[1]/100.0;
}
for(i=O;i<NumberOfData-1;i++) {
if(distance>r[i] && distance<r[i+1])
indice=i;
if(distance>r[NumberOfData-1])
indice=NumberOfData-1;
if(indice<NumberOfData-1) {
tableint=((log(r2J[indice])-log(r2J[indice+1]))*(r[indice]-distance))/(r[indice]-
r[indice+1]);
Svalue=exp(log(r2J[indice])-tableint);
Svalue=Svalue/(distance*distance);
Stotal=Stotal+Svalue;
Rays=Rays+ 1;
}
SumRays=SumRays+1;
//}//end of n-t
simulation
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if(SumRays> )Svalue=Stotal/SumRays;
if(icord==0
&& jcord== && kcord==0)Sooo=Svalue;
if
(Svalue>O.0O 1 *Sooo) {
printf("% d %d % d %s %f\n",icord,jcord,kcord,":",Svalue);
fprintf(fp3, " % d %d % d %s %f n",icord,jcord,kcord,":",Svalue);
}//end of n-th
simulation
}//end od if r<icord
}//end of icord
}//end of if r<jcord
}//end of jcord
}//end of if r<kcord
}//end of kcord
fclose(fp3);
}//end of main
/*functions' definitions*/
double nextrandnum ()
{
double retVal;
retVal = 1.0*rand () ;
/*adjusting the random numbers to less than 1*!
while (retVal > 1)
{
retVal = retVal / RANDMAX ;}
return retVal
double randomnoGenerator ()
{
double randNum, randNum2 ;
it randPow;
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/* generating randomnumbers between -1 and 1*/
randNum = next rand num );
randPow=randNum* 10;
randNum2 = next rand num);
randNum=pow(-1,randPow)*randNum2;
return (randNum);
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